Big Pharma trio backs cancer startup; AB jumps on ALS data; Shire founder oversees AIM listing

Nick Paul Taylor In this week's EuroBiotech Report, Metabomed celebrated adding Pfizer to a list of investors that already featured the VC units of Merck KGaA and Boehringer Ingelheim. ...

Medicines Co. jumps on rumors of a multibillion-dollar buyout

Damian Garde Drugmaker the Medicines Company saw its shares rise as high as 14% on rumors that the company may be up for sale. FierceBiotech News

Geron jumps as its J&J-partnered cancer drug shows promise in Phase II

Damian Garde Long-troubled drug developer Geron is touting what it calls "unprecedented" early results for its lead cancer drug, sending the biotech's share price up as ...

Gilead jumps into epigenetics with a bite-size biotech buyout

Damian Garde As market watchers wonder whether Gilead Sciences is on the verge of a blockbuster buyout, the Big Biotech inked a small deal that will beef up its efforts in the growing ...

Yervoy, Sprycel, Eliquis jumps help Bristol-Myers beat Q3 estimates

Carly Helfand The patent cliff may still be taking a toll on Bristol-Myers Squibb, but the company's Q3 sales haul was enough to impress analysts thanks to star performances from ...

PhRMA jumps into Integrilin off-label case, free-speech arguments at the ready

Tracy Staton Since a U.S. circuit court decided the First Amendment protected a pharma sales rep from off-label marketing charges, the free-speech arguments have multiplied in cases ...

Roche’s breast cancer franchise keeps delivering, with huge jumps for Perjeta, Kadcyla

Carly Helfand Blame a strong Swiss franc on any falling sales and profits Roche put up in the first half of 2014, the company said Thursday. The Swiss pharma's cancer drugs certainly ...

U.K. gov names ex-biotech VC as life sci chief, Genfit’s stock jumps, Woodford backs biotechs

Nick Paul Taylor In this week's EuroBiotech Report, the U.K. government underlined the importance it places on life sciences–and the jobs it brings–by creating a position ...

Epizyme jumps on $4M payday

John Carroll Shares of Cambridge, MA-based Epizyme jumped 10% this morning after the company announced that it had won a $ 4 million payment from GSK after hitting the third of the ...

Heart drug developer Trevena jumps into biotech IPO game with $86M pitch

John Carroll The King of Prussia, PA-based biotech says it was the first developer to get into the clinic with a GPCR biased ligand, a program which was inspired in part by scientific ...

AbbVie jumps into $405M CF deal with Galapagos

Tracy Staton AbbVie has inked a $ 405 million deal with Belgium's Galapagos to target genetic mutations in patients with cystic fibrosis. FiercePharma News

J&J 2Q Profit Jumps

barbara.lempert Johnson & Johnson Reports 2013 Second-Quarter Results: Sales of $ 17.9 Billion increased 8.5% Versus 2012 Second Quarter; Second-Quarter EPS was $ 1.33 Excluding ...
Page 1 of 212
© 2017 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS